Life Sciences

Policymakers should recognize that the potential of data-driven drug development is crucial to the well-being of Americans as well as U.S. competitiveness, and develop policies to accelerate this transformation.
Life Sciences
Check a box to narrow search for individual content items that cover numerous issues.
October 21, 2019
In response to increased public pressure, both Congress and the Trump Administration have recently promoted efforts to reduce the price of prescription drugs in the United States. Several other countries have already imposed measures of their own.
September 24, 2019
Val Giddings' presentation to the Breakthrough Institute at Ecomodernism 2019 explores research to improve the efficiency of photosynthesis and what this means for climate mitigation and the global economy.
September 18, 2019
Policymakers should recognize that the potential of data-driven drug development is crucial to the well-being of Americans as well as U.S. competitiveness, and develop policies to accelerate this transformation.
September 9, 2019
Academic studies consistently show that a reduction in current drug revenues leads to a fall in future research and the number of new drug discoveries.
August 12, 2019
China is challenging the United States for market share and jobs in one of the highest value-added, most innovation-intensive industries—and the risks extend not just to the U.S. economy, but to global biopharma innovation.
August 6, 2019
As Eline Chivot writes in Health Europa, EU policymakers should call for France and Germany to lift their bans on direct-to-consumer genetic testing and instead harmonize laws to create a single market.
June 20, 2019
ITIF hosted an expert panel discussion on impact drug-price controls have and what effect, if any, mandated drug-price reductions would have on biopharmaceutical innovation and U.S. industry competitiveness.
June 6, 2019
The United States must stand up for innovation in the debate over the U.S.-Mexico-Canada Agreement (USMCA), ITIF's Stephen Ezell, the Macdonald-Laurier Institute's Richard Owens, and Fundacion Idea's Alberto Saracho write in The Hill.
May 20, 2019
China’s patent output has grown dramatically in recent years, both in terms of the volume of patents submitted for international protection under the Patent Cooperation Treaty (PCT) and in terms of the number of citations those patents receive, a standard measure of a patent’s importance. New research breaking down the sources of those citations raises significant doubts about whether the growth in Chinese patent citations is as meaningful as it appears.
May 16, 2019
In testimony before the House Oversight Committee, Stephen Ezell explained why the United States leads the world in life-sciences innovation; how the public and private sectors contribute; why innovation depends on the ability to generate revenues; the consequences of price controls; and how best to control health-care costs.

Pages